Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Gynecol Oncol. 2016 Jul 9;142(3):566–573. doi: 10.1016/j.ygyno.2016.07.006

Figure 3.

Figure 3

Gene maps showing CpG regions with significant differences in percent (%) methylation between CIN1, CIN2, CIN3 and cervical cancer samples for (A) CDKN2A and (B) DAPK1 genes as measured by bisulfite sequencing. The mapped regions are shown by black bars. Box plots are shown for CpGs with significant statistical differences in methylation across lesion groups (uncorrected p<0.05), with comparisons that remained significant after Bonferroni correction marked by an asterisk.